Healwell adds Khure, Pentavere into AI engine

Executive Summary

• Healwell AI Inc. reported significant progress in integrating its AI platforms (Khure, Pentavere, and Darwen) into a unified engine and aligning clinical/commercial operations with Orion Health's global distribution network.
• The company is advancing its refocused strategy as a pure-play SaaS, services, and AI business, including portfolio simplification following recent divestments and evaluating strategic investments such as its stake in xAI/SpaceX.
• Early commercial traction is emerging for AI-enhanced software platforms like Amadeus AI across multiple global regions, supported by expanding scientific validation and clinical collaborations.

Key Details

• Completed integration of Khure and Pentavere AI capabilities into a unified AI engine powered by Darwen.
• Integrated clinical operations and commercial sales teams to drive operational and commercial scale.
• Expanded offerings across the joint customer base via coordinated Orion-Verosource commercial initiatives, targeting upsell/cross-sell opportunities and a robust commercial pipeline entering 2026.
• Amadeus AI (next-generation AI-enabled digital care record) has active commercial opportunities in Canada, the United States, Europe, and the Middle East.
• Integration of Healwell's AI into Orion Health's infrastructure shows early commercial traction, combining 30+ years of healthcare IT with Healwell's clinically validated AI and Verosource's data science capabilities.
• Darwen AI platform (Prix Galien award recipient) expanding disease-state coverage and life sciences customer base, with recent advancements in AI-driven label expansion and patient identification.
• Scientific validation: Four publications accepted in Q4 2025 (one in the Journal of the Canadian Association of Gastroenterology, two presented at United European Gastroenterology, one at the European Crohn's and Colitis Organisation); total peer-reviewed publications now exceed 50.
• Portfolio simplification: Following divestments announced Nov. 3, 2025, evaluating strategic investments including a $2 million USD investment in a dedicated vehicle holding an interest in xAI (now part of SpaceX per a Feb. 2, 2026 merger announcement), alongside smaller private healthcare tech investments.
• Strategic refocus: Transitioning to a pure-play SaaS, services, and AI business with an emphasis on AI-assisted preventive care, early disease detection, and expanding the "carriage network" for clinical outcomes.

Notable Quotes

• James Lee, CEO: "The integration of our AI platforms has been well received by customers and has translated directly into new opportunities for expanded life science partner agreements... This validates our focused strategy of building cohesive, enterprise-grade AI solutions that deliver real clinical and economic value."
• Dr. Alexander Dobranowski, President: "Health care IT adoption requires trust, validation and security, particularly in enterprise and public-sector environments... By embedding proven AI into established platforms with long-standing customer relationships, we believe we are uniquely positioned to drive adoption at scale."
• Mr. Lee: "Our strategy is clear: We are building a global carriage network to enable the adoption of AI-assisted preventive care through early disease detection... everything about Healwell, including our M&A strategy is deliberately focused on expanding our carriage network and our capabilities while keeping the patients and clinicians outcome at the very core of what we do."